Answers are grounded in this paper and cite their sources.
alteration was the most common mutation in therapy-related myelodysplastic syndrome, the finding was not detrimental in our case-series.
No takes yet. Share an insight, caveat, or question.
Aldoss et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: